These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 10920058)

  • 1. Selective endothelin-A versus combined endothelin-A/endothelin-B receptor blockade in rat chronic heart failure.
    Mulder P; Boujedaini H; Richard V; Derumeaux G; Henry JP; Renet S; Wessale J; Opgenorth T; Thuillez C
    Circulation; 2000 Aug; 102(5):491-3. PubMed ID: 10920058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective ETA receptor blockade prevents left ventricular remodeling and deterioration of cardiac function in experimental heart failure.
    Mulder P; Richard V; Bouchart F; Derumeaux G; Münter K; Thuillez C
    Cardiovasc Res; 1998 Sep; 39(3):600-8. PubMed ID: 9861302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early intervention with a potent endothelin-A/endothelin-B receptor antagonist aggravates left ventricular remodeling after myocardial infarction in rats.
    Oie E; Yndestad A; Robins SP; Børnerheim R; Asberg A; Attramadal H
    Basic Res Cardiol; 2002 May; 97(3):239-47. PubMed ID: 12061394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival and hemodynamics after endothelin-a receptor antagonism and angiotensin-converting enzyme inhibition in rats with chronic heart failure: monotherapy versus combination therapy.
    Mulder P; Boujedaini H; Richard V; Henry JP; Renet S; Münter K; Thuillez C
    Circulation; 2002 Aug; 106(9):1159-64. PubMed ID: 12196345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of endothelin in deterioration of heart failure due to cardiomyopathy in hamsters: increase in endothelin-1 production in the heart and beneficial effect of endothelin-A receptor antagonist on survival and cardiac function.
    Yamauchi-Kohno R; Miyauchi T; Hoshino T; Kobayashi T; Aihara H; Sakai S; Yabana H; Goto K; Sugishita Y; Murata S
    Circulation; 1999 Apr; 99(16):2171-6. PubMed ID: 10217659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin antagonism in experimental ischemic heart failure: hemodynamic, structural and neurohumoral effects.
    Mulder P; Richard V; Thuillez C
    Heart Fail Rev; 2001 Dec; 6(4):295-300. PubMed ID: 11447304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal and systemic effects of chronic blockade of ET(A) or ET(B) receptors in normal rats and animals with experimental heart failure.
    Francis B; Winaver J; Karram T; Hoffman A; Abassi Z
    J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S54-8. PubMed ID: 15838359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.
    Spinale FG; Walker JD; Mukherjee R; Iannini JP; Keever AT; Gallagher KP
    Circulation; 1997 Apr; 95(7):1918-29. PubMed ID: 9107181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardioprotection by long-term ET(A) receptor blockade and ACE inhibition in rats with congestive heart failure: mono- versus combination therapy.
    Fraccarollo D; Bauersachs J; Kellner M; Galuppo P; Ertl G
    Cardiovasc Res; 2002 Apr; 54(1):85-94. PubMed ID: 12062365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters.
    Honoré JC; Carrier E; Fecteau MH; Tirapelli CR; Bkaily G; D'Orleans-Juste P
    Can J Physiol Pharmacol; 2008 Jun; 86(6):394-401. PubMed ID: 18516103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endothelin receptor antagonists on ventricular susceptibility in postinfarcted rats.
    Lee TM; Chen CC; Lin MS; Chang NC
    Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1871-9. PubMed ID: 18281380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ET-receptor antagonism, myocardial gene expression, and ventricular remodeling during CHF in rats.
    Oie E; Bjønerheim R; Grogaard HK; Kongshaug H; Smiseth OA; Attramadal H
    Am J Physiol; 1998 Sep; 275(3):H868-77. PubMed ID: 9724291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endothelin receptors ET(A) and ET(B) blockade on renal haemodynamics in normal rats and in rats with experimental congestive heart failure.
    Abassi Z; Francis B; Wessale J; Ovcharenko E; Winaver J; Hoffman A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():245S-248S. PubMed ID: 12193096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT).
    Lüscher TF; Enseleit F; Pacher R; Mitrovic V; Schulze MR; Willenbrock R; Dietz R; Rousson V; Hürlimann D; Philipp S; Notter T; Noll G; Ruschitzka F;
    Circulation; 2002 Nov; 106(21):2666-72. PubMed ID: 12438291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-A receptor antagonism during acute myocardial infarction in rats.
    Pfeffer JM; Finn PV; Zornoff LA; Pfeffer MA
    Cardiovasc Drugs Ther; 2000 Dec; 14(6):579-87. PubMed ID: 11300358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
    New RB; Sampson AC; King MK; Hendrick JW; Clair MJ; McElmurray JH; Mandel J; Mukherjee R; de Gasparo M; Spinale FG
    Circulation; 2000 Sep; 102(12):1447-53. PubMed ID: 10993866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic therapy with an ET(A/B) receptor antagonist in conscious dogs during progression of congestive heart failure. Intracellular Ca(2+) regulation and nitric oxide mediated coronary relaxation.
    Shen YT; Buie PS; Lynch JJ; Krause SM; Ma XL
    Cardiovasc Res; 2000 Nov; 48(2):332-45. PubMed ID: 11054479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of endothelin-A receptor blockade during the progression of pacing-induced congestive heart failure.
    Saad D; Mukherjee R; Thomas PB; Iannini JP; Basler CG; Hebbar L; O SJ; Moreland S; Webb ML; Powell JR; Spinale FG
    J Am Coll Cardiol; 1998 Nov; 32(6):1779-86. PubMed ID: 9822109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.